answersLogoWhite

0

Myelodysplastic syndromes, also know as MDS, is a group of blood related disorders. These also involve ineffective production of blood cells of the myeloid class.

User Avatar

Wiki User

12y ago

What else can I help you with?

Related Questions

Which condition is also known as preleukemia?

Myelodysplastic syndrome (MDS) is often referred to as preleukemia because it can progress to acute myeloid leukemia (AML) in some cases. MDS is a group of disorders where the bone marrow does not produce enough healthy blood cells.


Will putting benzine in a zippo lighter be a good option?

Not unless your goal is to get aplastic amenia or MDS (myelodysplastic syndromes). Exposure to Benzene is a risk factor in developing these debilitating disease.


Can Myelodysplastic syndrome be prevented?

MDS does not appear to run in families, nor can it be spread to other individuals


How does Myelodysplastic syndrome affect the blood?

The blood cells of people with MDS do not mature normally


Is Myelodysplastic syndrome more common in men?

MDS is slightly more common in males than in females


Can you catch Myelodysplastic Anaemia?

No you can not catch myelodysplastic anaemia from other people, as is the case for any type of anaemia. Myelodysplatic syndromes are characterised by ineffective production of myeloid blood cells (any white blood cell, excluding lymphocytes). Anaemia is a very common side effect of this type of disease. It is thought to be caused by exposure to environmental factors such as radiation. As it is caused by a defect in the production of blood cells, this can not be passed on from person to person.


What is the survival rate for Myelodysplastic syndrome?

The survival rate for Myelodysplastic Syndromes (MDS) varies widely depending on factors such as the specific subtype of MDS, the patient's age, overall health, and response to treatment. Generally, the median survival ranges from about 20 months to several years, with some patients living much longer, especially those who undergo successful treatment such as stem cell transplantation. Prognostic scoring systems, like the Revised International Prognostic Scoring System (IPSS-R), can help estimate individual survival chances. Regular monitoring and personalized treatment plans are crucial for improving outcomes.


Are MGUS and MDS related?

Monoclonal gammopathy of undetermined significance (MGUS) and myelodysplastic syndromes (MDS) are both hematologic conditions, but they are not directly related. MGUS is characterized by the presence of an abnormal monoclonal protein in the blood without significant symptoms or organ damage, while MDS involves a group of disorders caused by poorly formed or dysfunctional blood cells, often leading to anemia and other complications. However, both conditions can increase the risk of developing more serious blood disorders, including multiple myeloma in the case of MGUS and acute myeloid leukemia in the case of MDS.


How is Myelodysplastic syndrome divided?

MDS is divided into five different subtypes that are classified according to the number and appearance of blast cells in the bone marrow


Does Myelodysplastic syndrome result in increased bleeding?

Another symptom of MDS is increased bleeding


What is the significance of micromegakaryocytes in peripheral blood?

micromegakaryocytes are typically seen in the peripheral blood in Myelodysplastic Syndromes (MDS) which are considered "pre-leukemia" syndromes because a high proportion of them progress to acute leukemia.Micromegakaryocytes are caused by dysmegakaryocytopoiesis, meaning the bone marrow is not making normal megakaryocytes. Other megakaryocyte abnormalities may include large megakaryocytes that lack normal nuclear segmention, megs with two or more small unconnected nuclei, and "mononuclear" megs that lack normal nuclear lobation.


Where can one find information on myelodysplastic syndrome foundation?

Myelodysplastic syndrome is a disorder affecting the bone marrow. The foundation for this syndrome has an official site called MDS-Foundation. It has information about the disease for both patients and their doctors, as well as information on clinical trials, and how one can donate.